China’s Jiangsu Hansoh Pharmaceutical is planning to raise up to $3 billion in a Hong Kong initial public offering later this year, tapping demand to invest in China’s growing health-care market.
from WSJ.com: US Business http://ift.tt/1OwQaji
via IFTTT
No comments:
Post a Comment